Sera Prognostics, Inc.

5.50 USD
+0.45 (+8.91%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sera Prognostics, Inc. stock is up 179.19% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November.

About Sera Prognostics, Inc.

Sera Prognostics, Inc. develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.